Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Radiation-Hardened Component Supply (Specialty Subassembly)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334413
New
DIBBS
SWITCH, THERMOSTATIC
Solicitation # SPE7M8-26-T-6376
Solicitation SPE7M8-26-T-6376 is a fixed-price request for 78 thermostatic switches, identified by NSN 5930-01-155-7762. This is a critical application item governed by source control drawing SPE7M8-26-T-6376, with approved sources including Oshkosh Defense LLC. The procurement is managed by the DLA Land and Maritime Electrical Devices Division, with a need ship date of January 19, 2027, and an original required delivery date of March 3, 2027. Delivery is set as FOB Origin, with inspection and acceptance occurring at the destination, specifically the DLA Distribution DDSP New Cumberland facility in Pennsylvania. The contract mandates strict adherence to technical and quality requirements, including the DLA Master List (RA001) and specific packaging standards. Non-hazardous materials must be packaged per ASTM D3951, while hazardous materials require IP025 compliance and labeling according to the Hazard Communication Standard. Palletization must follow RP001, and all marking must comply with MIL-STD-129. Quality assurance is enforced through sampling methods such as MIL-STD-1916 or ASQ H1331, with a zero-non-conformance requirement for MIL-STD-105/ASQ Z1.4. Additionally, the use of Class I ozone-depleting substances is prohibited without written approval, and additive manufacturing is not authorized. Offerors must comply with the Berry Amendment, the Buy American Act, and DFARS 252.204-7012 for safeguarding covered defense information.
ELECTRICAL DEVICES DIV

POSTED

about 15 hours ago

DEADLINE

in 4 days

AI Contract Overview

Show more

This contract involves the supply of specialized radiation-hardened components or subassemblies, including sensor panels, scintillators, and readout electronics that can endure radiation exposure of 2,000 Gray or higher. It is designated as a subcontract under the NAICS code 334413 and is managed by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The work is to be performed in Silver Spring, with a focus on delivering components suitable for high-radiation environments, ensuring durability and functionality under such conditions. The solicitation was posted on May 15, 2026, with a response deadline set for May 21, 2026, at 2:00 PM. Although there is no specified type of set-aside for this subcontract, it highlights the need for vendors capable of providing specialty electronic subassemblies that meet rigorous radiation tolerance standards, supporting the agency's mission likely related to health and safety applications.

General Info

Supply of radiation-hardened sensor panels and electronics, subcontract under FDA, Silver Spring, May 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334413 - Semiconductor and Related Device ManufacturingView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

This scope was carved out of CDRH-2026-123668.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Flat Panel Detector

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of radiation-tolerant components or subassemblies such as sensor panels, scintillators, or readout electronics capable of withstanding ≥ 2,000 Gy exposure.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS